Large-scale testing (Phase 3)Study completedNCT00168805
What this trial is testing
RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery
Who this might be right for
Arthroplasty, Replacement, KneeThromboembolism
Boehringer Ingelheim 2,101